At the time of writing, Checkpoint Therapeutics Inc [CKPT] stock is trading at $4.04, saw in change for the day. An important factor to consider is whether the stock is rising or falling in short-term value. The CKPT shares have lost -0.49% over the last week, with a monthly amount glided 57.50%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Checkpoint Therapeutics Inc [NASDAQ: CKPT] stock has seen the most recent analyst activity on January 13, 2025, when D. Boral Capital initiated its Buy rating and assigned the stock a price target of $9. On June 09, 2021, B. Riley Securities initiated with a Buy rating and assigned a price target of $18 on the stock. Cantor Fitzgerald started tracking the stock assigning a Overweight rating and suggested a price target of $16 on January 20, 2021. Lake Street initiated its recommendation with a Buy. H.C. Wainwright started tracking with a Buy rating for this stock on December 08, 2017, and assigned it a price target of $11.
For the past year, the stock price of Checkpoint Therapeutics Inc fluctuated between $1.38 and $4.50. Currently, Wall Street analysts expect the stock to reach $4.1 within the next 12 months. Checkpoint Therapeutics Inc [NASDAQ: CKPT] shares were valued at $4.04 at the most recent close of the market. An investor can expect a potential return of 1.49% based on the average CKPT price forecast.
Analyzing the CKPT fundamentals
According to Checkpoint Therapeutics Inc [NASDAQ:CKPT], the company’s sales were 0.04M for trailing twelve months, which represents an -100.00% plunge. Gross Profit Margin for this corporation currently stands at -451.68% with Operating Profit Margin at -798.17%, Pretax Profit Margin comes in at -988.68%, and Net Profit Margin reading is -988.68%. To continue investigating profitability, this company’s Return on Assets is posted at -8.97, Equity is 3.6 and Total Capital is 2.98.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 4.02 points at the first support level, and at 4.00 for the second support level. However, for the 1st resistance point, the stock is sitting at 4.06, and for the 2nd resistance point, it is at 4.08.
Ratios To Look Out For
It is important to note that Checkpoint Therapeutics Inc [NASDAQ:CKPT] has a current ratio of 0.37. On the other hand, the Quick Ratio is 0.37, and the Cash Ratio is 0.26. Considering the valuation of this stock, the price to sales ratio is 8460.25.
Transactions by insiders
Recent insider trading involved Oliviero James F III, CEO, President and Director, that happened on Feb 10 ’25 when 10331.0 shares were sold. CEO, President and Director, Oliviero James F III completed a deal on Feb 07 ’25 to sell 9233.0 shares. Meanwhile, Chief Financial Officer GRAY WILLIAM GARRETT sold 74110.0 shares on Feb 06 ’25.
